From Target to Molecule – A Comprehensive Guide to Antibody Discovery and Development
At least 570 monoclonal antibodies (mAbs) have already been progressed to the clinic by commercial companies. This process is long, with most companies taking approximately 12 years to move from the first patent filing to FDA approval. The multi-year journey may feel overwhelming, but it can be broken up into short-term goals and milestones that allow you to stay present for the full exhilarating experience.
Download this guide to learn more about the stages of antibody development including:
